These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 963239)

  • 1. Conversion of fibrinogen to fibrin. The correlation between clotting kinetics and morphology of fibrin polymerized in different solvent media.
    Conio G; Trefiletti V; Troglia C; Patrone E
    Biopolymers; 1976 Oct; 15(10):1979-90. PubMed ID: 963239
    [No Abstract]   [Full Text] [Related]  

  • 2. An analysis of the clotting curves of complex dynamic rigidity for fibrinogen-thrombin solutions.
    Kaibara M; Fukada E
    Biorheology; 1980; 17(3):255-9. PubMed ID: 7213992
    [No Abstract]   [Full Text] [Related]  

  • 3. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conversion of fibrinogen to fibrin. XIII. Dissolution of fibrin and inhibition of clotting by various neutral salts.
    SHULMAN S; KATZ S; FERRY JD
    J Gen Physiol; 1953 Jul; 36(6):759-66. PubMed ID: 13069679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion.
    Andrades ME; Lorenzi R; Berger M; Guimarães JA; Moreira JC; Dal-Pizzol F
    Chem Biol Interact; 2009 Aug; 180(3):478-84. PubMed ID: 19397901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect in vitro of lanthanum, yttrium and cerium chlorides on the 1st phase of the thrombin-fibrinogen reaction].
    Ducastaing A; Monceyron C; Azanza JL; Creac'h P; Raymond J
    C R Seances Soc Biol Fil; 1973; 167(2):262-9. PubMed ID: 4802769
    [No Abstract]   [Full Text] [Related]  

  • 8. The assembly and structure of the fibrin clot.
    Mosesson MW
    Nouv Rev Fr Hematol (1978); 1992; 34(1):11-6. PubMed ID: 1523091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some symmetry considerations for the fibrinogen-fibrin assembly system.
    Doolittle RF
    J Supramol Struct; 1974; 2(2-4):138-49. PubMed ID: 4474572
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization.
    Nakayama-Hamada M; Suzuki A; Furukawa H; Yamada R; Yamamoto K
    J Biochem; 2008 Sep; 144(3):393-8. PubMed ID: 18583356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease.
    Kim PY; Stewart RJ; Lipson SM; Nesheim ME
    J Thromb Haemost; 2007 Jun; 5(6):1250-6. PubMed ID: 17266698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheology of blood coagulation.
    Kaibara M
    Biorheology; 1996; 33(2):101-17. PubMed ID: 8679959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin].
    Kudriashov BA; Liapina LA; Molchanova LV; Rustamova BA
    Vopr Med Khim; 1970; 16(2):161-8. PubMed ID: 4247358
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology.
    Lipinski B; Wegrzynowicz Z; Budzynski AZ; Kopeć M; Latallo ZS; Kowalski E
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):65-77. PubMed ID: 5584961
    [No Abstract]   [Full Text] [Related]  

  • 17. Transformation of fibrinogen into fibrin. III. Kinetics of the pH change associated with the clotting of fibrinogen.
    MIHALYI E; BILLICK IH
    Biochim Biophys Acta; 1963 Apr; 71():97-108. PubMed ID: 13935712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 20. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.